MAP2K3 293T Cell Transient Overexpression Lysate(Denatured)

Catalog # H00005606-T01

Size

Price

Stock

Quantity

Size:100 uL
Price: USD $ 247.00
Stock:
order now, ship in 6 weeks
abnova-minus
abnova-plus

* The price is valid only in USA. Please select country.

Contact Info
  • +1-909-264-1399
    +1-909-992-0619
    Toll Free : +1-877-853-6098
  • +1-909-992-3401
Images
SDS-PAGE Gel
QC Test

SDS-PAGE Gel

MAP2K3 transfected lysate.

Western Blot
QC Test

Western Blot

Lane 1: MAP2K3 transfected lysate ( 38.28 KDa)
Lane 2: Non-transfected lysate.

  • Specification

    Transfected Cell Line

    293T

    Plasmid

    pCMV-MAP2K3 full-length

    Host

    Human

    Theoretical MW (kDa)

    38.28

    Quality Control Testing

    Transient overexpression cell lysate was tested with Anti-MAP2K3 antibody (H00005606-B01) by Western Blots.

    SDS-PAGE Gel

    MAP2K3 transfected lysate.

    Western Blot

    Lane 1: MAP2K3 transfected lysate ( 38.28 KDa)
    Lane 2: Non-transfected lysate.

    Storage Buffer

    1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)

    Storage Instruction

    Store at -80°C. Aliquot to avoid repeated freezing and thawing.

  • Applications

    Western Blot

  • Gene Info — MAP2K3

    Entrez GeneID

    5606

    GeneBank Accession#

    NM_145109.1

    Protein Accession#

    NP_659731.1

    Gene Name

    MAP2K3

    Gene Alias

    MAPKK3, MEK3, MKK3, PRKMK3

    Gene Description

    mitogen-activated protein kinase kinase 3

    Omim ID

    602315

    Gene Ontology

    Hyperlink

    Gene Summary

    The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is activated by mitogenic and environmental stress, and participates in the MAP kinase-mediated signaling cascade. It phosphorylates and thus activates MAPK14/p38-MAPK. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of RAS oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of MAPK14, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis. Multiple alternatively spliced transcript variants that encode distinct isoforms have been reported for this gene. [provided by RefSeq

    Other Designations

    MAP kinase kinase 3|MAPK/ERK kinase 3|OTTHUMP00000166044|dual specificity mitogen activated protein kinase kinase 3

  • Interactome
  • Pathway
Contact Info
  • +1-909-264-1399
    +1-909-992-0619
    Toll Free : +1-877-853-6098
  • +1-909-992-3401
4 Products to Compare
Remove All